Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy.

"CONFLICT OF INTEREST The public health‐care administration for Region Uppsala in Sweden has, on behalf of the National Prostate Cancer Register, made agreements on subscriptions for quarterly reports from Patient‐overview Prostate Cancer with Astellas, Sanofi, Janssen and Bayer, as well as research projects with Astellas, Bayer and Janssen. Stacy Loeb reports previous equity in Gilead from a family member. Region Uppsala has, on behalf of NPCR, made agreements on subscriptions for quarterly reports quarterly reports from Patient‐overview Prostate Cancer with Astellas, Janssen and Bayer, as well as research projects with Astellas, Bayer and Janssen. All remaining authors have declared no conflicts of interest."

"Funding information Swedish Research Council, Grant/Award Number: 2020‐05866"